Perennial Allergic Rhinitis Study In Pediatric Subjects
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00108914|
Recruitment Status : Completed
First Posted : April 21, 2005
Last Update Posted : January 19, 2017
|Condition or disease||Intervention/treatment||Phase|
|Rhinitis, Allergic, Perennial||Drug: GW685698X||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||558 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||A Two Week Randomized, Double Blind Placebo Controlled, Parallel Group Study of GW685698X Aqueous Nasal Spray 100mcg and 50mcg QD in Pediatric Subjects With Perennial Allergic Rhinitis|
|Study Start Date :||February 2005|
|Primary Completion Date :||November 2005|
|Study Completion Date :||November 2005|
- Improvement in daily, reflective total nasal symptom scores after first 4-week treatment period in subjects ages 6 to <12 years.
- Improvement in AM, pre-dose, instantaneous total nasal symptom scores after first 4-week treatment period, overall evaluation of response to therapy for the first 4-week treatment period for subjects ages 6 to <12 years.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00108914
Show 66 Study Locations
|Study Director:||GSK Clinical Trials||GlaxoSmithKline|